secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2026-06-10T10:01:35+00:00
Accession:  0001156039-26-000049
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health reaffirms FY2026 adjusted EPS at least $26.75, benefit expense ratio ~90.2%
--------------------------------------------------------------------------------

- Reaffirms FY2026 GAAP EPS guidance at least $19.85, including ~$6.90 net unfavorable items.
- Adjusted shareholders' earnings guidance unchanged at at least $26.75 per diluted share.
- Benefit expense ratio guidance reaffirmed at 90.2% ± 50 basis points.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000049/0001156039-26-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000049/elv-20260610.htm
  HTML page:      https://secwatch.observer/filing/0001156039-26-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer